Muutke küpsiste eelistusi

E-raamat: Regulating Pre-Implantation Genetic Diagnosis: A Comparative and Theoretical Analysis [Taylor & Francis e-raamat]

Edited by (University of Glasgow, UK), Edited by (University of Glasgow, UK)
  • Taylor & Francis e-raamat
  • Hind: 193,88 €*
  • * hind, mis tagab piiramatu üheaegsete kasutajate arvuga ligipääsu piiramatuks ajaks
  • Tavahind: 276,97 €
  • Säästad 30%
"The successful achievement of pregnancies after pre-implantation genetic diagnosis (PGD) was reported in April 1990. The technology is often used for patients who are at substantial risk of conceiving a pregnancy affected by a known genetic disorder, however from this technology other more controversial uses have arisen such as HLA typing to save the life of a sibling, sex selection for social reasons, the prevention of late onset diseases, or to prevent diseases which may be genetically predisposed to developing such as breast cancer. The technology surrounding PGD is constantly developing, giving rise to new and unexpected consequences that create fresh ethical and legal dilemmas. Featuring internationally recognized experts in this field this book critically explores the regulation of PGD and the broader legal and ethical issues. It looks at the regulatory situation in a number of jurisdictions including New Zealand, Asutralia and the UK, but it also explores a number of themes of wide significance including a historical consideration of PGD and its part in the creation of the "genetic embryo" as a political tool, the over-regulation of PGD, the place of the woman in the regulation of PGD and the ethical difficulties in handling this additional unexpected medical information yielded by new technologies"--

"The successful achievement of pregnancies following pre-implantation genetic diagnosis (PGD) was first reported in April 1990. The technology is often used for patients who are at substantial risk of conceiving a pregnancy affected by a known genetic disorder, however from this technology other more controversial uses have arisen such as HLA typing to save the life of a sibling, gender selection for social reasons, the prevention of late onset diseases, or the prevention of diseases which may be genetically predisposed to developing such as breast cancer. The technology surrounding PGD is constantly developing, giving rise to new and unexpected consequences that create fresh ethical and legal dilemmas. Featuring internationally recognized experts in thefield, this book critically explores the regulation of PGD and the broader legal and ethical issues associated with it. It looks at the regulatory situation in a number of jurisdictions including New Zealand, Australia and the United Kingdom, but it alsoexplores a number of themes of wide significance including a historical consideration of PGD and its part in the creation of the "genetic embryo" as a political tool, the over regulation of PGD and the ethical difficulties in handling additional unexpected medical information yielded by new technologies. This book will be of particular interest to academics and students of law, medicine and ethics"--

The successful achievement of pregnancies following pre-implantation genetic diagnosis (PGD) was first reported in April 1990. The technology is often used for patients who are at substantial risk of conceiving a pregnancy affected by a known genetic disorder, however from this technology other more controversial uses have arisen such as HLA typing to save the life of a sibling, gender selection for social reasons, the prevention of late onset diseases, or the prevention of diseases which may be genetically predisposed to developing such as breast cancer. The technology surrounding PGD is constantly developing, giving rise to new and unexpected consequences that create fresh ethical and legal dilemmas.

Featuring internationally recognized experts in the field, this book critically explores the regulation of PGD and the broader legal and ethical issues associated with it. It looks at the regulatory situation in a number of jurisdictions including New Zealand, Australia and the United Kingdom, but it also explores a number of themes of wide significance including a historical consideration of PGD and its part in the creation of the "genetic embryo" as a political tool, the over regulation of PGD and the ethical difficulties in handling additional unexpected medical information yielded by new technologies. This book will be of particular interest to academics and students of law, medicine and ethics.

Notes on contributors ix
Introduction 1(3)
Sheila A.M. Mclean
1 Pre-implantation genetic diagnosis: safely born but not designed
4(13)
Peter Braude
2 The weak moral basis for strong PGD regulation
17(22)
Tom Campbell
Laura Cabrera
3 PGD and the making of the `genetic embryo' as a political tool
39(32)
Martin H. Johnson
Anastasia A. Theodosiou
4 Statutory regulation of PGD in the UK: unintended consequences and future challenges
71(18)
Emily Jackson
5 The welfare of the child principle and the use of PGD: selecting for disability
89(37)
Sarah Elliston
6 Regulating abortion and pre-implantation genetic diagnosis in the Australian states of New South Wales, Victoria and Western Australia: comparing and contrasting regulative approaches
126(22)
Kerry Petersen
7 Regulatory legitimacy: the case for controlling and restricting access to PGD for sex-selection purposes
148(23)
Don Chalmers
8 Cartwright calamities, Frankenstein monsters and the regulation of PGD in New Zealand
171(28)
Jeanne Snelling
9 The state in action: an insider's view of how the state regulates the use of PGD with HLA tissue-typing in New Zealand
199(25)
Mark Henaghan
Thomas Cleary
Conclusion 224(15)
Sheila A.M. Mclean
Sarah Elliston
Index 239
Sheila A. McLean is the first holder of the International Bar Association Chair of Law and Ethics in Medicine at Glasgow University and is Director of the Institute of Law and Ethics in Medicine at Glasgow University. She has acted as a consultant to the World Health Organisation and the Council of Europe, and to individual States.



Sarah Elliston is Senior Lecturer at the University of Glasgow, UK.  In addition to her work at the university, she has contributed to the work of a number of public and professional organisations. She is the Scottish Case Editor for the Butterworths Medico Legal Reports and writes the medical law section for the Butterworths Scottish Older Client Law Service.